Tag: europe

FLORENCE, Italy and NEW YORK, June 14, 2026 (GLOBE NEWSWIRE) -- The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. (“Stemline”), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to cancer patients, announced that new data related to the pivotal Phase 3 SENTRY trial will be presented as a late-breaking oral at The European Hematology Association (EHA) 2026 Congress.

RIYADH, Saudi Arabia, June 14, 2026 (GLOBE NEWSWIRE) -- At HLTH Europe 2026 in Amsterdam, taking place from June 15 to 18, King Faisal Specialist Hospital & Research Centre (KFSH) will highlight that the value of artificial intelligence in healthcare is measured not by technological complexity alone, but by its ability to give clinicians more time, patients better experiences, and health systems greater capacity to deliver specialized care.

RIYADH, Arabie saoudite, 14 juin 2026 (GLOBE NEWSWIRE) -- Au HLTH Europe 2026 à Amsterdam, du 15 au 18 juin, le King Faisal Specialist Hospital & Research Centre (KFSH) soulignera le fait que la valeur de l’intelligence artificielle dans les soins de santé est mesurée non seulement par sa complexité technologique seule, mais aussi par sa capacité à offrir plus de temps aux cliniciens, de meilleures expériences aux patients et une capacité accrue aux systèmes de santé, pour délivrer des soins spécialisés.

RIAD, Saudi-Arabien, June 14, 2026 (GLOBE NEWSWIRE) -- Auf der HLTH Europe 2026 in Amsterdam, die vom 15. bis 18. Juni stattfindet, wird das King Faisal Specialist Hospital & Research Centre (KFSH) hervorheben, dass der Wert künstlicher Intelligenz im Gesundheitswesen nicht allein an der technologischen Komplexität gemessen wird, sondern an ihrer Fähigkeit, Ärzten mehr Zeit, Patienten bessere Erfahrungen und Gesundheitssystemen größere Kapazitäten für die Bereitstellung spezialisierter Versorgung zu verschaffen.

Media Release

COPENHAGEN, Denmark; June 13, 2026

Réunis à Istanbul, des spécialistes de renom en allergologie exploreront les moyens par lesquels la science, la prévention et les politiques peuvent réduire l’impact mondial des maladies allergiques

RIYADH, Saudi Arabia, June 13, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH) will use its participation at HLTH Europe 2026, taking place from June 15 to 18 in Amsterdam, to advance a clear message: artificial intelligence in healthcare will only scale when institutions can prove that it is safe, reliable, governed, and trusted by clinicians and patients.

 -- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI z-score reductions, reductions in fat mass with preservation of lean mass, and improvements in hyperphagia and anxiety measures --   

-- Positive results reinforce rationale for Phase 3 development of MC4R agonism in PWS --